Alphatec Holdings Inc (NASDAQ:ATEC)’s Trend Unknown, Especially After Increased Shorts

October 2, 2018 - By whatsonthorold

Alphatec Holdings, Inc. (NASDAQ:ATEC) Logo

The stock of Alphatec Holdings Inc (NASDAQ:ATEC) registered an increase of 18.59% in short interest. ATEC’s total short interest was 551,700 shares in October as published by FINRA. Its up 18.59% from 465,200 shares, reported previously. With 205,000 shares average volume, it will take short sellers 3 days to cover their ATEC’s short positions.

The stock decreased 2.24% or $0.07 during the last trading session, reaching $3.06. About 72,213 shares traded. Alphatec Holdings, Inc. (NASDAQ:ATEC) has risen 41.13% since October 2, 2017 and is uptrending. It has outperformed by 25.51% the S&P500.

Alphatec Holdings, Inc., a medical technology company, focuses on the design, development, manufacture, and marketing of products for the surgical treatment of spine disorders. The company has market cap of $129.73 million. The Company’s product and procedural portfolio, as well as pipeline address the cervical, thoracolumbar, and intervertebral regions of the spine; and cover various spinal disorders and surgical procedures. It currently has negative earnings. The firm offers MIS products consisting of Battalion Lateral Spacer System and Squadron Lateral Retractor, XYcor Expandable Spinal Spacer System, Illico Minimally Invasive Surgery System, and BridgePoint Spinous Process Fixation System; and thoracolumbar fixation products, such as Arsenal Degenerative, Arsenal Deformity, Arsenal CBx Cortical Bone Fixation, and Zodiac Degenerative Spinal Fixation systems.

More news for Alphatec Holdings, Inc. (NASDAQ:ATEC) were recently published by: Nasdaq.com, which released: “Alphatec Accelerates Organic Innovation Machine With Addition of Key Senior Leadership and Expansion of Market …” on September 27, 2018. Globenewswire.com‘s article titled: “Alphatec Advances Clinical Distinction With OsseoScrew® Clearance” and published on September 26, 2018 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>